首页> 外文学位 >STUDIES OF TECHNETIUM AND RHENIUM DIPHOSPHINE COMPLEXES, AND SOME CATIONIC TECHNETIUM COMPLEXES OF SCHIFF BASE LIGANDS, AS MYOCARDIAL IMAGING AGENTS (RADIOPHARMACEUTICALS).
【24h】

STUDIES OF TECHNETIUM AND RHENIUM DIPHOSPHINE COMPLEXES, AND SOME CATIONIC TECHNETIUM COMPLEXES OF SCHIFF BASE LIGANDS, AS MYOCARDIAL IMAGING AGENTS (RADIOPHARMACEUTICALS).

机译:作为心肌成像剂(放射性药物)的S夫碱配体的OF和AND二膦配合物以及某些阳离子配合物的研究。

获取原文
获取原文并翻译 | 示例

摘要

The ultimate goal of this research is the development of an efficacious ('99m)Tc myocardial imaging agent. This thesis describes (i) the application of inorganic and analytical techniques to the preparation and characterization of cationic technetium-99 and rhenium complexes in macroscopic amounts, and (ii) the preparation and biological evaluation of these, and other, complexes using ('99m)Tc and ('186)Re at the very low concentrations of these isotopes encountered in nuclear medicine.;Cationic diphosphine complexes of technetium were prepared in the V, III and I oxidation states. The Tc(V) and Tc(III) complexes can be represented as tr- TcD(,2)Y(,2) ('+) where D is a diphospine such as 1,2-bis(dimethylphosphino)ethane and Y is O, Cl, Br, or I. The Tc(I) complex can be represented as TcD(,3) ('+). Analogous rhenium complexes in the III and I states were also prepared using both nonradioactive rhenium and ('186)Re. These cationic complexes, prepared with ('99m)Tc, were evaluated as myocardial imaging agents in different animal models. In vivo evaluation of the ('186)Re-diphosphine analogs has provided insight into the role played by oxidation-reduction processes in determining myocardial accumulation of the ('99m)Tc-diphosphine complexes.;A novel class of cationic ('99m)Tc radiopharmaceuticals has been prepared using tetradentate Schiff base ligands. The Tc(V) parent complexes, ('99m)TcLO ('+) (L = tetradentate Schiff base), form cationic Tc(III) mixed ligand complexes upon reaction with monodentate phosphines, phosphites or isonitriles (as for example, tr- ('99m)TcL(PR(,3))(,2) ('+)). The properties of these complexes can be readily varied over wide ranges by altering the nature of the equatorial Schiff base and/or the axial monodentate ligands. In vivo evaluation of selected complexes indicates definite myocardial uptake and it is very likely that one member of this new class of cationic ('99m)Tc mixed ligand complexes will be an efficacious myocardial imaging agent.;The ('99)Tc and Re complexes have been characterized by classical chemical techniques including (1) single-crystal x-ray analysis, (2) elemental analysis, (3) spectroscopy (IR, visible-UV, and/or NMR), (4) extended x-ray absorption fine structure analysis (EXAFS), (5) electrochemistry, and (6) high performance liquid chromotography analysis (HPLC). The ('99m)Tc complexes have been characterized by comparison of their HPLC retention times with the retention times of standard solutions of their ('99)Tc analogues. Thus HPLC comprises the link between macroscopic ('99)Tc chemistry and microscopic ('99m)Tc chemistry.
机译:这项研究的最终目标是开发有效的('99m)Tc心肌显像剂。本论文描述了(i)无机和分析技术在宏观量阳离子tech 99和rh配合物的制备和表征中的应用,以及(ii)使用('99m Tc和('186)Re在核医学中遇到的这些同位素的非常低的浓度。V的阳离子二膦配合物以V,III和I氧化态制备。 Tc(V)和Tc(III)配合物可以表示为tr- TcD(,2)Y(,2)('+),其中D为双膦,例如1,2-双(二甲基膦基)乙烷,Y为O,Cl,Br或I。Tc(I)络合物可以表示为TcD(,3)('+)。还使用非放射性rh和('186)Re制备了处于III和I状态的类似rh配合物。用('99m)Tc制备的这些阳离子复合物在不同动物模型中被评估为心肌显像剂。 ('186)Re-二膦类似物的体内评估提供了对氧化还原过程在确定('99m)Tc-二膦复合物的心肌积累中所起的作用的洞察力;一类新型的阳离子('99m)已使用四齿席夫碱配体制备了Tc放射性药物。 Tc(V)母体复合物('99m)TcLO('+)(L =四齿席夫碱)在与单齿膦,亚磷酸酯或异腈(例如tr- ('99m)TcL(PR(,3))(,2)('+))。通过改变赤道席夫碱和/或轴向单齿配体的性质,可以很容易地在很宽的范围内改变这些配合物的性质。体内对选定复合物的评估表明心肌有明确的摄取,这种新型阳离子('99m)Tc混合配体复合物中的一员很有可能是一种有效的心肌显像剂;('99)Tc和Re复合物。经典化学技术的特征包括:(1)单晶X射线分析,(2)元素分析,(3)光谱学(IR,可见光和/或NMR),(4)扩展X射线吸收精细结构分析(EXAFS),(5)电化学和(6)高效液相色谱分析(HPLC)。 ('99m)Tc络合物的特征是通过将其(HPLC)保留时间与('99)Tc类似物的标准溶液的保留时间进行比较。因此,HPLC包括宏观('99)Tc化学和微观('99m)Tc化学之间的联系。

著录项

  • 作者

    VANDERHEYDEN, JEAN-LUC E.;

  • 作者单位

    University of Cincinnati.;

  • 授予单位 University of Cincinnati.;
  • 学科 Chemistry Analytical.
  • 学位 Ph.D.
  • 年度 1985
  • 页码 300 p.
  • 总页数 300
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号